2-amino-N-methoxy-N-methylbenzenesulfonamide, 10g

(2S,4S,5S)-1-TERT-BUTYL 2-METHYL 4-HYDROXY-5-METHYLPYRROLIDINE-1,2-DICARBOXYLATE, 90.0%, 100mg

Ethyl 3-amino-3-(3-chlorophenyl)propanoate hydrochloride, 95%, 250mg

4'-Hydroxyacetophenone>98.0%(HPLC)(T)500g

Plan PLPH 10x/0.25 phase contrast objective

5-(AMINOMETHYL)PYRIDIN-3-AMINE 2HCL, 95.0%, 1g

(S)-4,5-Diamino-5-oxopentanoic acid, 95.0%, 5g

Methyl Benzenesulfonate>98.0%(GC)25mL

3-(2-fluorophenoxy)azetidine hydrochloride, 95.0%, 1g

[4-(Trifluoromethyl)phenyl]acetic acid methyl ester, 99.0%, 250mg

2-((tert-Butoxycarbonyl)(pentyl)amino)acetic acid, 95%, 500mg

1-(Adamantan-1-yl)-3-mesityl-4,5-dihydro-1H-imidazol-3-ium chloride, 97%, 250mg

7,8-Difluorochroman-4-amine, 95.0%, 1g